<DOC>
	<DOCNO>NCT02904772</DOCNO>
	<brief_summary>The aim study provide confirmatory evidence clinical benefit LPLD patient treat alipogene tiparvovec assess `` clinical response '' ( defined range parameter ) , `` metabolic response '' ( postprandial CM metabolism ) LPLD patient without immunosuppressant regimen .</brief_summary>
	<brief_title>Alipogene Tiparvovec Treatment LPLD Patients</brief_title>
	<detailed_description>This prospective , interventional , randomised , open-label , parallel group study evaluate clinical response well dynamic postprandial chylomicron metabolism patient treat alipogene tiparvovec without immunosuppressant . The study conduct 12 LPLD patient randomise Immuno+ ( cyclosporin mycophenolate mofetil ) Immuno- group .</detailed_description>
	<mesh_term>Hyperlipoproteinemia Type I</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Main inclusion criterion : Patients history severe multiple pancreatitis attack despite dietary fat restriction . Genetically confirm diagnosis LPLD Postheparin plasma LPL protein mass &gt; 5 % normal LPL activity â‰¤20 % normal ( post heparin plasma ) Fasting plasma TG concentration &gt; 10 mmol/L . Main exclusion criterion : Females positive pregnancy test breastfeeding , contraceptive use . Patients positive HIV , Hepatitis B , Hepatitis C positive tuberculosis . Patients treatment antiplatelet anticoagulant . Patient allergic condition prohibits use immunosuppressant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>